Cooper Companies (NASDAQ:COO) Updates Q2 2026 Earnings Guidance

Cooper Companies (NASDAQ:COO) updated its second quarter 2026 earnings guidance on Thursday. The company provided EPS guidance of 4.580-4.660 for the period, compared to the consensus EPS estimate of 1.070. The company issued revenue guidance of $4.3 billion-$4.3 billion, compared to the consensus revenue estimate of $1.1 billion.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on COO. KeyCorp restated a “sector weight” rating on shares of Cooper Companies in a research report on Friday, December 5th. The Goldman Sachs Group reiterated a “sell” rating and set a $73.00 price target on shares of Cooper Companies in a research note on Friday, January 9th. Citigroup cut their price target on shares of Cooper Companies from $88.00 to $87.00 and set a “neutral” rating for the company in a report on Friday. Mizuho set a $100.00 price objective on shares of Cooper Companies and gave the company an “outperform” rating in a research report on Friday, December 5th. Finally, Morgan Stanley lifted their price objective on Cooper Companies from $76.00 to $83.00 and gave the company an “equal weight” rating in a report on Monday, December 8th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, seven have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $90.79.

Cooper Companies Price Performance

Cooper Companies stock opened at $76.55 on Friday. The company has a market cap of $14.94 billion, a P/E ratio of 37.90, a price-to-earnings-growth ratio of 2.29 and a beta of 1.02. Cooper Companies has a one year low of $61.78 and a one year high of $89.83. The business has a fifty day moving average of $82.11 and a two-hundred day moving average of $75.97. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.13 and a current ratio of 1.89.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings results on Thursday, March 5th. The medical device company reported $1.10 earnings per share for the quarter, topping analysts’ consensus estimates of $1.03 by $0.07. The business had revenue of $1.02 billion for the quarter, compared to analysts’ expectations of $1.02 billion. Cooper Companies had a net margin of 9.67% and a return on equity of 10.36%. The business’s revenue for the quarter was up 6.2% on a year-over-year basis. During the same period in the prior year, the company posted $0.92 EPS. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. As a group, analysts predict that Cooper Companies will post 3.98 earnings per share for the current fiscal year.

Insider Activity at Cooper Companies

In other news, Director Maria Rivas purchased 1,000 shares of the firm’s stock in a transaction dated Thursday, December 18th. The shares were acquired at an average price of $82.13 per share, with a total value of $82,130.00. Following the purchase, the director directly owned 11,141 shares of the company’s stock, valued at $915,010.33. The trade was a 9.86% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Holly R. Sheffield purchased 1,230 shares of the stock in a transaction that occurred on Tuesday, December 16th. The stock was purchased at an average price of $80.75 per share, for a total transaction of $99,322.50. Following the acquisition, the insider owned 39,052 shares in the company, valued at approximately $3,153,449. This trade represents a 3.25% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders acquired a total of 16,014 shares of company stock valued at $1,304,416 in the last ninety days. Company insiders own 2.08% of the company’s stock.

Trending Headlines about Cooper Companies

Here are the key news stories impacting Cooper Companies this week:

• Positive Sentiment: Q1 beat and guidance lift — COO reported a Q1 EPS beat and management raised FY26 EPS and free‑cash‑flow guidance, citing robust momentum in MyDay and MiSight and margin expansion. This is the main fundamental positive supporting longer‑term upside. Read More.
• Positive Sentiment: Bullish analyst activity — Multiple firms increased targets/ratings today (Barclays raised its target to $103 and Needham to $101; William Blair maintained a Buy), signaling continued conviction from several sell‑side analysts. This creates potential catalyst if buyers follow through. Read More.
• Neutral Sentiment: Favorable growth profile highlighted by screens — Recent writeups (Zacks, other screens) point to above‑average financial growth and attractive style scores, which may keep the stock on growth‑oriented portfolios but don’t guarantee near‑term momentum. Read More.
• Neutral Sentiment: Product/clinical news supports long run thesis — CooperVision research and product initiatives were highlighted at NCC 2026, reinforcing the durability of the contact‑lens franchise. That’s positive strategically but not an immediate catalyst. Read More.
• Negative Sentiment: Market punished the stock despite the beat — Several outlets noted shares fell after the report because revenue was roughly in‑line or slightly short of some street models and investors flagged regional headwinds and sluggish core vision trends. That helped drive the intraday selloff. Read More.
• Negative Sentiment: Mixed analyst/street positioning — Citigroup trimmed its target to $87 and issued Neutral, and Morgan Stanley stayed on Hold, reflecting differing views on near‑term recovery in core vision that can limit upside until clearer top‑line improvement is visible. Read More.

Institutional Trading of Cooper Companies

A number of institutional investors have recently bought and sold shares of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its stake in shares of Cooper Companies by 48.9% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 22,407 shares of the medical device company’s stock worth $1,890,000 after buying an additional 7,363 shares during the last quarter. First Trust Advisors LP grew its stake in Cooper Companies by 115.8% in the 2nd quarter. First Trust Advisors LP now owns 136,334 shares of the medical device company’s stock valued at $9,702,000 after acquiring an additional 73,165 shares during the last quarter. Cresset Asset Management LLC purchased a new position in Cooper Companies during the 2nd quarter valued at about $291,000. Cerity Partners LLC increased its holdings in Cooper Companies by 4.4% during the 2nd quarter. Cerity Partners LLC now owns 17,870 shares of the medical device company’s stock valued at $1,272,000 after acquiring an additional 757 shares in the last quarter. Finally, Daiwa Securities Group Inc. raised its position in Cooper Companies by 2.8% during the second quarter. Daiwa Securities Group Inc. now owns 35,839 shares of the medical device company’s stock worth $2,551,000 after acquiring an additional 973 shares during the last quarter. 24.39% of the stock is currently owned by hedge funds and other institutional investors.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.